Related Documents
-
Notice: Food for human consumption: Hospira, Inc., et al.; approval withdrawn
836 reads -
Notice: Biological products:
Patent extension; regulatory review period determinations— Protamine sulfate injection, etc.
82 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— DURICEF (cefadroxil USP) tablets, 1 gram, and capsules, 500 milligrams
87 reads -
Notice: Human drugs:
New drug applications— Able Laboratories, Inc.; approval withdrawn
61 reads -
Notice: Human drugs:
New drug applications— Able Laboratories, Inc.; approval withdrawn
85 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
29 reads -
belajarmembuatwebsite
588 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— REVLIMID
56 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— LAMICTAL (lamotrigene) Tablets, 50 and 250 milligrams
69 reads -
Arti Huruf Depan Anda
1300 reads -
Notice: Meetings:
22 reads -
Notice: Meetings: Health Care Policy and Research Special Emphasis Panel
13 reads -
Notice: Human drugs:
New drug applications— King Pharmaceuticals, Inc., et al.; approval withdrawn
70 reads -
Notice: Human drugs:
New drug applications— INSPRA
195 reads -
Am Ox It Id
1931 reads -
How to Install Windows XP
1216 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Prevacid naprapac
47 reads -
Notice: Committees; establishment, renewal, termination, etc.: Medical Devices Advisory Committee
36 reads -
Norainil Hawa Apakah Itu Blog
188 reads





More from this Publisher
More from this Publisher
Related Documents
Flag this document
6 Pages